The post EIP-8141 and the End of the Dumb Wallet appeared on BitcoinEthereumNews.com. // News Reading time: 2 min Published: Mar 02, 2026 at 13:42 Ethereum co-founderThe post EIP-8141 and the End of the Dumb Wallet appeared on BitcoinEthereumNews.com. // News Reading time: 2 min Published: Mar 02, 2026 at 13:42 Ethereum co-founder

EIP-8141 and the End of the Dumb Wallet

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
// News
Reading time: 2 min

Published: Mar 02, 2026 at 13:42

Ethereum co-founder Vitalik Buterin has officially ended a decade-long wait by unveiling EIP-8141, an “omnibus” proposal that fundamentally rewrites how users interact with the blockchain.


Announced on February 28, 2026, this upgrade finally solves the “Account Abstraction” puzzle that has haunted the network since 2016. The centerpiece of this revolution is a concept called “Frame Transactions.” Instead of the rigid, “one-action-one-signature” model we’ve suffered through for years, transactions are now being reimagined as a series of $N$ programmable calls.

What does this mean for the average person?


Essentially, your wallet is becoming a smart computer rather than a digital lockbox. EIP-8141 allows for atomic operations—like approving a token and spending it in a single click—and introduces “Paymasters,” which let you pay gas fees in stablecoins or even have them sponsored by the app you’re using.


Most importantly, it removes the “middlemen” like relayers and third-party broadcasters. Vitalik’s goal is “intermediary minimization,” ensuring that even if the world’s centralized infrastructure collapses, Ethereum remains a “non-ugly, cypherpunk” sanctuary. This isn’t just a technical tweak; it’s the bridge to a future where your grandmother can use DeFi without needing a degree in computer science.


Disclaimer. The data provided is collected by the author and is not sponsored by any company or token developer. This is not a recommendation to buy or sell cryptocurrency and should not be viewed as an endorsement by Coinidol.com. Readers should do their research before investing in funds.

Source: https://coinidol.com/vitalik-omnibus-mic-drop/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09